Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R1KE
|
|||
Former ID |
DNC006920
|
|||
Drug Name |
2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid
|
|||
Synonyms |
CHEMBL214655; 2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid; 2-[4-bromo-2-(hydroxymethyl)phenoxy]acetic acid; AC1LHWL0; AH-487/41804565; SCHEMBL3201339; MolPort-002-091-532; ZINC470785; HMS1590C02; BDBM50200250; MCULE-6729250214; SR-01000266540
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H9BrO4
|
|||
Canonical SMILES |
C1=CC(=C(C=C1Br)CO)OCC(=O)O
|
|||
InChI |
1S/C9H9BrO4/c10-7-1-2-8(6(3-7)4-11)14-5-9(12)13/h1-3,11H,4-5H2,(H,12,13)
|
|||
InChIKey |
QMNTWAAGYOSTJK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin D2 receptor 2 (PTGDR2) | Target Info | Inhibitor | [1] |
Reactome | Prostanoid ligand receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem. 2006 Nov 16;49(23):6638-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.